|
|
40
|
|
|
A6812
|
|
|
COMBIVIR 150MG | 300MG TAB (GSK/COL) LAMIVUDINE | ZIDOVUDINE
|
|
|
LAMIVUDINE|ZIDOVUDINE
|
|
|
COMBIVIR
|
|
|
60'S
|
|
|
BL
|
|
|
135.02
|
|
|
2.25
|
|
|
150MG|300MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
GSK
|
|
|
GLAXOSMITHKLINE
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2022-05-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
08180892
|
|
|
ANTIRETROVIRALS MISCELLANEOUS
|
|
|
Delete from contract
|
|
|
Oral
|
|
|
0
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
2022-04-19
|